References
- Tan C., Rosen G., Ghavimi F., et al. Cancer Chemother. Rep. 1975; 6(part 3)259–266
- Wang J. J., Holland J. F., Sinks L. F. Cancer Chemother. Rep. 1975; 6(part 3)267–270
- Davis H. L., Davis T. E. Cancer Treat. Rep. 1979; 63: 809–815
- Harris P. A., Gross J. F. Cancer Chemother. Rep. 1975; 59(part 1)819–825
- Blum R. H., Carter S. K. Ann. Intern. Med. 1974; 80: 249–259
- Benjamin R. S. Cancer Chemother. Rep. 1975; 6(part 3)183–185
- Bachur N. R. Cancer Chemother. Rep. 1975; 6(part 3)153–158
- Bachur N. R. Cancer Treat. Rep. 1979; 63: 817–820
- Lee Y. -T. N., Chan K. K., Harris P. A., Cohen J. L. Cancer 1980; 45: 2231–2239
- Chan K. K., Cohen J. L., Gross J. F., et al. Cancer Treat. Rep. 1978; 62: 1161–1171
- Alberts D. S., Bachur N. R., Holtzman J. L. Clin. Pharmacol. Ther. 1972; 12: 96–104
- Rosso R., Ravazzoni C., Esposito M., et al. Eur. J. Cancer 1972; 8: 455–459
- Langone J. J., Vanshis H. V., Bachur N. R. Biochem. Med. 1975; 12: 283–289
- Benjamin R. S., Wiernik P. H., Bachur N. R. Cancer 1974; 33: 19–27
- Benjamin R. S., Riggs C. E., Bachur N. R. Clin. Pharmacol. Ther. 1973; 14: 592–600
- Creasey W. A., McIntosh L. S., Brescia T., et al. Cancer Res. 1976; 36: 216–221
- Bachur N. R., Riggs C. E., Green M. R., et al. Clin Pharmacol. Ther. 1977; 21: 70–77
- Riggs C. E., Benjamin R. S., Serpick A. A., Bachur N. R. Clin. Pharmacol. Ther. 1977; 22: 234–241
- Benjamin R. S., Riggs C. E., Bachur N. R. Cancer Res. 1977; 37: 1416–1420
- Chan K. K., Chlebowski R. T., Tong M., et al. Cancer Res. 1980; 40: 1263–1268
- Huffman D. H., Bachur N. R. Blood 1972; 39: 637–643
- Benjamin R. S. Cancer Chemother. Rep. 1975; 6(part 3)191–194
- Reich S. D., Bachur N. R. Cancer Res. 1976; 36: 3803–3806
- Nilsson S. -O., Andersson B., Eksberg S., et al. Cancer Chemother. Pharmacol. 1981; 5: 261–266
- Evans W. E., Williams D., Forrester L., et al. Drug Intell. Clin. Pharm. 1980; 14: 634, (abstract)
- Atwell G. J., Cain B. F., Seelye R. N. J. Med. Chem. 1972; 15: 611–615
- Arlin Z. A., Sklaroff R. B., Gee T. S., Kempin S. J., Howard J., Clarkson B. D., Young C. W. Cancer Res. 1980; 40: 3304–3306
- Rivera G., Evans W. E., Dahl G. V., Yee G. C., Pratt C. B. Cancer Res. 1980; 40: 4250–4253
- McCredie K. B., Keating M. J., Estey E. H., Zander A., Bodey G. P., Drewinko B., Freireich E. J. Proc. Am. Soc. Clin. Oncol. 1981; 22: 479, (abstract)
- Gormley P. E., Cysyk R. Anal. Biochem. 1979; 96: 504–507
- Stanbus A., Neidhart J., Young D., Malspeis L. Proc. Am. Assoc. Cancer Res. 1980; 21: 1981, (abstract)
- Cysyk R. L., Shoemaker D., Anderson R. H. Drug Metab. Dispos 1977; 5: 579
- Przybylski M., Adamson R. H., Mean J. A. R., et al. Proc. Am. Assoc. Cancer Res. 1979; 20: 287
- Malspeis L., Bhat H. B., Padmanahban S., et al. Proc. Am. Assoc. Cancer Res. 1980; 21: 308
- Shoemaker D., Gormley P., Monks A., et al. Proc. Am. Assoc. Cancer Res. 1980; 21: 308
- Shoemaker D. D., Gormley P. E., Cysyk R. L. Drug Metab. Dispos. 1980; 8: 467–468
- Hall S. W., Benjamin R. S., Legha S. S., et al. Proc. Am. Assoc. Cancer Res. 1979; 20: 175, (abstract)
- Bunger R. M., Peisach J., Horwitz S. B. Life Sci. 1981; 28: 715–727
- Yagado A., Mukherji B., Young C., Etcubanas E., Lamonte C., Smith J. R., Tan C. T. C., Karkoff I. H. Ann. Intern. Med. 1972; 77: 861–870
- Haas C. D., Coltman C. A., Gottlieb J. A., Hart A., Luce J. K., Talley R. W., Samal B., Wilson H. E., Hoogstraten B. Cancer 1976; 38: 8–12
- Bonadonna G., Delena M., Monfardini S., Bartoli C., Bajetta E., Beretta G., Fossati-Bellani G. Eur. J. Cancer 1972; 8: 205–215
- Exelby P. R. Semin. Oncol. 1979; 6: 116–120
- Yee G. C., Crom W. R., Brodeur G. M., Champion J. E., Gutierrez M. L., Lee F. H., Evans W. E. Clin. Pharmacol. Ther. 1983; 33: 668–673
- Broughton A., Strong J. E. Cancer Res. 1976; 36: 1418–1421
- Krakoff I. H., Critkovic E., Crurie V., Yeh S., Laraonte C. Cancer 1977; 40: 2027–2037
- Alberts D. S., Chen H. S. G., Liu R., Himmelstein K. J., Mayersohn M., Penier D., Gross J., Moon T., Broughton A., Salmon S. E. Cancer Chemother. Pharmacol. 1978; 1: 177–181
- Broughton A., Strong J. E., Holoye P. Y., Bedrossian C. W. M. Cancer 1977; 40: 2772–2778
- Green A. A., Hayes F. A., Pratt C. B., et al. Cisplatin–Current Status and New Developments, A. W. Prestayko, S. T. Crooke, S. K. Carter. Academic Press, New York 1980
- Ochs J. J., Freeman A. I., Douglass H. O., Jr., et al. Cancer Treat. Rep. 1978; 63: 239–245
- LeRoy A. F., Lutz R. J., Dedrick R. L., et al. Cancer Treat. Rep. 1979; 63: 59–71
- Casper E. S., Kelsen D. P., Alcock W. W., et al. Cancer Treat. Rep. 1979; 63: 2023–2025
- Vermarhen J. B., van der Veigh W. J. F., Pinedo H. M. Res. Commun. Chem. Pathol. Pharmacol. 1980; 28: 319–328
- DeSimone P. A., Yancy R. S., Coupal J. J., et al. Cancer Treat. Rep. 1979; 63: 951–960
- Crom W. R., Evans W. E., Pratt C. B., et al. Cancer Chemother. Pharmacol. 1981; 6: 95–99
- Gullo J. J., Litterst C. L., Maguire P. J., et al. Cancer Chemother. Pharmacol. 1980; 5: 21–26
- Prestayko A. W., D'Aoust J. C., Issel B. J., Crooke S. T. Cancer Treat. Rev. 1979; 6: 17–39
- Litterst C. L., Gram T. E., Dedrick R. L., et al. Cancer Res. 1976; 36: 2340–2344
- Lange R. C., Spencer R. P., Harder H. C. J. Nucl. Med. 1972; 13: 328–330
- Lange R. C., Spencer R. P., Harder H. C. J. Nucl. Med. 1973; 14: 191–195
- Smith P. H. S., Taylor D. M. J. Nucl. Med. 1974; 15: 349–351
- Long D. F., Repta A. J. Biopharmaceutics Drug Dispos. 1981; 2: 1–16
- DeConti R. C., Joftness B. R., Lange R. C., Creasy W. A. Cancer Res. 1973; 33: 1310–1315
- Gormley P. E., Bull J. M., LeRoy A. F., Cysyk R. Clin. Pharmacol. Ther. 1979; 25: 351–357
- Repta A. J., Long D. F. Cisplatin–Current Status and New Developments, A. W. Prestayko, S. T. Crooke, S. K. Carter. Academic Press, New York 1980; 285–304
- Patton T. F., Himmelstein K. J., Belt R., et al. Cancer Treat. Rep. 1978; 62: 1359–1362
- Frick G. A., Ballentine R., Driver C. W., Kramer W. G. Cancer Treat. Rep. 1979; 63: 13–16
- Belt R. J., Himmelstein K. V., Patton T. F., et al. Cancer Treat. Rep. 1979; 63: 1515–1521
- Himmelstein K. J., Patton T. F., Belt R. J., et al. Clin. Pharmacol. Ther. 1981; 29: 658–664
- LeRoy A. G., Wehling M., Gormley P., et al. Cancer Treat. Rep. 1980; 64: 123–132
- Chang Y., Sternson L. A., Repta A. J. Anal. Lett. Bull. 1978; 449–459
- Sladek N. E., Priest J., Doeden D., et al. Cancer Treat. Rep. 1980; 64: 1061
- Mellett L. B., El Dareer S. M., Rail D. P., Adamson R. H. Arch. Int. Pharmacodyn. Ther. 1969; 177: 59
- Friedman O. M., Boger E. Anal. Chem. 1961; 33: 906
- Fenselau C., Kan M. -N. M., Rao S., et al. Cancer Res. 1977; 37: 2538
- Jardine I., Fenselau C., Appier M., et al. Cancer Res. 1978; 38: 408
- Juma F. D., Rogers H. J., Trounce J. R. Br. J. Clin. Pharmacol. 1980; 10: 327
- Pantarotto C., Bossi A., Belvedere G., et al. J. Pharm. Sci. 1974; 63: 1554
- Juma F. D., Rogers H. J., Trounce J. R. Br. J. Clin. Pharmacol. 1979; 8: 209
- Bagley C. M., Jr., Bostin F. W., DeVita V. T., Jr. Cancer Res. 1973; 33: 226
- Cohen J. L., Jao J. Y., Jusko W. J. Br. J. Pharmacol. 1971; 43: 677
- Duncan J. H., Colvin M. O., Fenselau C. Toxicol. Appl. Pharmacol. 1973; 24: 317
- Talha M. R., Rogers H. V., Trounce J. R. Br. J. Cancer 1980; 41: 140
- Edwarts G., Calvert R. T., Crowther D., Bramwell V., Scarffe H. Br. J. Clin. Pharmacol. 1980; 10: 281
- Mouridsen H. T., Jacobsen E. Acta Pharmacol. Toxicol. 1975; 409
- Grochon L. B., Colvin M. Clin. Pharmacokinet. 1979; 4: 380
- Conners T. A. Cancer Chemotherapy, H. M. Pinedo. Elsevier/North Holland, New York 1979; 30–40
- Brock N., Stekar J., Pohl J., Niemeyer U., Scheffler G. Arzneim. Forsch. 1979; 29: 659
- Scheef W., et al. Cancer Treat. Rep. 1979; 63: 501
- Levy L., Harris R. Biochem. Pharmacol. 1977; 26: 1015–1020
- Alberts D. S., van Daalen Wetters T. Cancer Res. 1976; 16: 2785
- Alberts D. S., Peng Y. M., Chen H. S., Struck R. F. Br. J. Cancer 1978; 38: 316
- Jao J. Y., Jusko W. J., Cohen J. L. Cancer Res. 1972; 32: 2761
- Donelli M. G., Franchi G., Rosse R. Eur. J. Cancer 1970; 6: 125–126
- Alberts D. S., van Daalen Wetters T. Cancer Res 1976; 36: 2790
- D'Incalci M., Bolis G., Facchinetti T., et al. Eur. J. Cancer 1979; 15: 7
- Mouridsen H. T., Faber O., Skovsted L. Cancer 1976; 37: 665
- Gurtoo H. L., Gessner T., Culliton P. Cancer Treat. Rep. 1976; 60: 1285
- Gerzon K. Anticancer Agents Based on Natural Products Models, J. M. Cassady, J. D. Douros. Academic Press, New York 1980; 271–317
- Jackson D. V., Bender R. A. Clinical Pharmacology of Anti-Neoplastic Drugs, H. M. Pinedo. Elsevier/North Holland, Biomedical Press, Amsterdam 1978; 277–293
- Nelson R. L., Dyke R. W., Root M. A. Cancer Treat. Rep. 1980; 7: 17–24
- Holland J. F., Glidewell O. Cancer 1972; 30: 1480
- Handbook on drugs of choice. 1977, Med. Lett
- James D. H., George P. J. Pediatr. 1964; 64: 534–541
- Windmiller J., Berry D. H., Haddy T. B. Am. J. Dis. Child. 1966; 3: 175–178
- Sutow W. W., Berry D. H., Haddy T. B., Sullivan M. P., Watkins W. L., Windmiller J. Pediatrics 1966; 38: 465–471
- Bohannon R. A., Miller D. G., Diamond H. D. Cancer Res. 1963; 23: 613–621
- Stakling K. A., Donaldson M. H., Haggard M. E. Am. J. Dis. Child. 1972; 123: 105–110
- Einhorn L. H., Donahue J. Ann. Intern. Med. 1977; 87: 293
- Gralla R. J., Tan C. T., Young C. W. Cancer Chemother. Pharmacol. 1979; 2(4)271–274
- Mathe G., Pico J. L., Schwarzenberg L., Riband D., Musset M., Jasmin C. L., DeLuca L. Cancer Treat. Rep. 1978; 62: 805–809
- Krivit W., Chilcote R., Pyesmany A., Anderson J., Hammond D. Cancer Chemother. Pharmacol. 1979; 2: 267–270
- Hill B. T., Whelan R. D. H. Cancer Treat. Rev. 1980; 7: 5–15
- Valdivieso M. Cancer Treat. Rev. 1980; 7: 31–37
- Krivit W., Anderson J., Chilcote R., Pyesmany A., Chard R., Glammond D. Am. J. Pediatr. Hem. J Oncol. 1980; 2: 217–221
- Maral R., Bourat C. H., Chenu E., Mathe G. Cancer Themother. Pharmacol. 1981; 5: 197–199
- Tan C. Current chemotherapy. Proc. 10th Int. Congress of Chemotherapy. Zurich September, 1977; vol. 2
- Nelson R. L., Dyke R. W., Root M. A. Clin. Pharmacol. Ther. 1977; 21: 112
- Bender R. A., Castle M. C., Margileth D. A., Oliverio V. T. Clin. Pharmacol. Ther. 1977; 22: 430–438
- Creasy W. A., Scott A. I., Wei C. C., Kutcher J., Schwartz A., March J. C. Cancer Res. 1975; 35: 1116–1120
- The Anticancer Drugs, W. B. Pratt, R. W. Rudden. Oxford University Press, New York 1979; 227
- Jackson D. V., Castbe M. C., Bender R. A. Clin. Pharmacol. Ther. 1978; 24: 101–107
- Woods W. G., O'Leary M., Nesbit M. E. J. Pediatr. 1981; 98: 642–645
- Owellen R. J., Hartke C. A., Hains F. O. Cancer Res. 1977; 37: 2597–2602
- Castle M. C., Mead J. A. R. Biochem. Pharmacol. 1978; 27: 37–44
- Kelly M. G., Hartwell J. L. J. Natl. Cancer Inst. 1954; 14: 967
- Brewer F. C., Loike J. D., Horwitz S. B., Sternlicht H., Gensler W. J. J. Med. Chem. 1979; 22: 215–221
- Grieder A., Maurer R., Stahelin H. Cancer Res. 1974; 34: 1788–1793
- Misra N., Roberts D. Cancer Res. 1975; 35: 99–105
- Rivera G., Avery T., Pratt C. Cancer Chemother. Rep. 1975; 59: 743–749
- Bleyer W. A., Krivit W., Chard R. L., Hammond D. Cancer Treat. Rep. 1979; 63: 977–981
- Rivera G., Green A., Hayes A. Cancer Treat. Rep 1977; 1243–1248
- Rozencweig M., Von Hoff D. D., Henney J. E., et al. Cancer 1977; 40: 334–342
- Seiler R. W. Helv. Pediatr. Acta 1980; 35: 51–56
- Slansky B. D., Mann-Kaplan R. S., Reynolds A. F., et al. Cancer 1974; 33: 460–467
- Issell B. F., Crooke S. T. Cancer Treat. Rep. 1979; 6: 107
- Muffia F. M., Selawry O. S., Hansen H. H. Cancer Chemother. Rep 1971; 55: 575–581
- Brunner W., Sonntag R. W., Ryssel H. J., Cavailli F. Cancer Treat. Rep. 1976; 60: 1377–1379
- D'Incalci M., Farina P., Fosoli M., et al. Proc. Am. Soc. Clin. Oncol. 1981; 99: 357
- Vendetti J. M. Cancer Chemother. Rep. 1971; 2: 35–59
- Dombernowsky P., Nissen N. I. Arch. Path. Microbiol. Scand. 1973; 81: 715–724
- Evans W. E., Sinkule J. A., Crom W. R., et al. Cancer Chemother. Pharmacol. 1982; 7: 147
- Snodgrass W., Walker L., Tubergen D., et al. Proc. Am. Assoc. Cancer Res. 1980; 21: 333
- Strife R. J., Jardine I., Colvin M. J. Chromatogr 1981; 224: 168
- Allen L. A., Creaven P. J. Eur. J. Cancer 1975; 11: 697
- Allen L. A., Marcks C., Creaven P. J. Proc. Am. Assoc. Cancer Res. 1976; 21: 6
- Evans W. E., Sinkule J. A., Rivera G., Dow L., Look T., et al. Proc. Am. Assoc. Cancer Res. 1981; 22: 174
- D'lncalci M., Farina P., Sessa R., Conter P., et al. Mario Negri Institute, Milan, Italy 1981, personal communications
- Elion G. B., Hitchings A. H., Van der Werff H. J. Biol. Chem. 1951; 192: 505–518
- Burchenal J. H., Murphy M. L., Ellison R. R., et al. Blood 1953; 8: 965–999
- Calabresi P., Parks R. E. The Pharmacological Basis of Therapeutics, Gilman, Goodman, Gilman. Macmillan, New York 1980
- Ding T. L., Benet L. Z. Drug Metab. Disp. 1979; 7: 373–378
- Loo T. L., Luce J. K., Sullivan M. P., Frei E. Clin. Pharmacol. Ther. 1968; 9: 180–194
- Coffey J. J., White C. A., Lesk A. B., et al. Cancer Res. 1972; 32: 1283–1289
- Tterlikkis L., Ortega E., Soloman R., Day J. L. J. Pharm. Sci. 1977; 66: 1454–1457
- Grindley G. B. Cancer Treat. Rev. 1979; 6: 19–25
- Elion G. B. Fed. Proc. 1967; 26: 898–904
- Bennett L. L., Allan P. W. Cancer Res. 1971; 31: 152–158
- Vogler W. R., Bain J. A., Huguley C. M., et al. Am. J. Med. 1966; 40: 548–559
- Goldin A., Vendetti J. M., Humphreys S. R., et al. J. Natl. Cancer Inst. 1955; 15: 1657
- Haskell C. M. Cancer Treatment, C. M. Haskell. W. B. Saunders, Philadelphia 1980; 79
- Valerino D. M., Johns D. G., Zaharko D. S., Oliverio V. T. Biochem. Pharmacol. 1972; 21: 821
- Smith D. K., Omura G. A., Ostroy F. Cancer Chemother. Pharmacol. 1980; 4: 117
- Henderson E. S., Adamson R. H., Oliverio V. T. Cancer Res. 1965; 25: 1018
- Wan S. H., Huffman D. H., Azarnoff D. L., et al. Cancer Res. 1974; 34: 3487
- Cohen M. H., Creaven P. J., Fossieck B. E., et al. Cancer 1976; 38: 1556
- Shen D. D., Azarnoff D. L. Clin. Pharmacokinet. 1978; 3: 1
- Freeman-Narrod M., Gerstly B. J., Engstrom P. F., Bornskin R. S. Cancer 1975; 36: 1619
- Lerne P. R., Creaven P. J., Allen L. M., Berman M. Cancer Chemother. Rep. 1975; 59: 811
- Pratt C. B., Howarth C., Evans W. E., et al. Cancer Treat. Rep. 1980; 64: 11
- Zaharko D. S., Dedrick R. L., Bischoff K. B., et al. J. Natl. Cancer Inst. 1971; 46: 775
- Bischoff K. B., Dedrick R. L., Zaharko D. S., Longsheth J. A. J. Pharm. Sci. 1971; 60: 1128
- Evans W. E., Pratt C. B. Clin. Pharmacol. Ther. 1978; 23: 68
- Evans W. E. Applied Pharmacokinetics – Principles of Therapeutic Drug Monitoring, W. E. Evans, J. J. Schentag, W. J. Jusko. Applied Therapeutics. 1980; 518
- Evans W. E., Hutson P. R., Stewart C. F., Crom W. R. Clin. Pharmacol. Ther. 1983; 33: 301–307
- Jacobs S. A., Stoller R. G., Chabner B. A., Johns D. G. J. Clin. Invest. 1976; 57: 534
- Johns D. G., Loo T. L. J. Pharm. Sci. 1967; 56: 356
- Wang Y. M., Howell S. K., Smith R. G., et al. Proc. Am. Soc. Clin. Oncol. 1979; 20: 334
- Baugh C. M., Krumdieck C. L., Nair M. G. Bio-chem. Biophys. Res. Commun. 1973; 52: 27
- Whitehead V. M., Penault M. M., Stelener S. Cancer Res. 1975; 35: 2985
- Balinska M., Galivan J., Coward J. K. Cancer Res. 1981; 41: 2751–2756
- Huffman D. H., Wan S. H., Azarnoff D. L., Hoogstraten B. Clin. Pharmacol. Ther. 1973; 14: 572
- Evans W. E., Tsiatis A., Crom W. R., Brodeur G., Coburn T., Pratt C. B. J. Pharm. Sci. 1981; 70: 1194
- Liegler D. G., Henderson E. S., Hahn M. A., Oliverio V. T. Clin. Pharmacol. Ther. 1969; 10: 849
- Evans W. E., Stewart C. F., Hutson P. R., Cairnes D. A., Bowman W. P., Yee G. C., Crom W. R. Drug Intel. Clin. Pharm. 1982; 16: 839–842
- Wang Y., Sutow W. W., Romsdahl M. M., Perey C. Cancer Treat. Rep. 1979; 63: 405
- Isacoff W. H., Morrison P. F., Aroesty J., et al. Cancer Treat. Rep. 1977; 61: 1665
- Lawrence J. R., Steele W. H., Stuart J. F. B., et al. Eur. J. Clin. Pharmacol. 1980; 17: 371